Subsequently, several literatures [33,34] also have reported that the prognostic scoring system established by RAI14, AXL, and NOX4 genes can accurately predict the prognosis of gastric cancer patients and their sensitivity to immunotherapy; and another Risk Score model based on 5 glycolysisimmume-related genes, including RAI14, was reliable in predicting the prognosis of osteosarcoma. This evidence concerns the gene RAI14 and osteosarcoma.